Literature DB >> 22544702

IKKα-mediated signaling circuitry regulates early B lymphopoiesis during hematopoiesis.

Mumtaz Yaseen Balkhi1, Jami Willette-Brown, Feng Zhu, Zhisong Chen, Shuang Liu, Denis C Guttridge, Michael Karin, Yinling Hu.   

Abstract

Multiple transcription factors regulate B-cell commitment, which is coordinated with myeloid-erythroid lineage differentiation. NF-κB has long been speculated to regulate early B-cell development; however, this issue remains controversial. IκB kinase-α (IKKα) is required for splenic B-cell maturation but not for BM B-cell development. In the present study, we unexpectedly found defective BM B-cell development and increased myeloid-erythroid lineages in kinase-dead IKKα (KA/KA) knock-in mice. Markedly increased cytosolic p100, an NF-κB2-inhibitory form, and reduced nuclear NF-κB p65, RelB, p50, and p52, and IKKα were observed in KA/KA splenic and BM B cells. Several B- and myeloid-erythroid-cell regulators, including Pax5, were deregulated in KA/KA BM B cells. Using fetal liver and BM congenic transplantations and deleting IKKα from early hematopoietic cells in mice, this defect was identified as being B cell-intrinsic and an early event during hematopoiesis. Reintroducing IKKα, Pax5, or combined NF-κB molecules promoted B-cell development but repressed myeloid-erythroid cell differentiation in KA/KA BM B cells. The results of the present study demonstrate that IKKα regulates B-lineage commitment via combined canonical and noncanonical NF-κB transcriptional activities to target Pax5 expression during hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544702      PMCID: PMC3369682          DOI: 10.1182/blood-2012-01-401547

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

Authors:  Benjamin L Hsu; Susan M Harless; R Coleman Lindsley; David M Hilbert; Michael P Cancro
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

2.  IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

Authors:  F Mercurio; H Zhu; B W Murray; A Shevchenko; B L Bennett; J Li; D B Young; M Barbosa; M Mann; A Manning; A Rao
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  A fourth IkappaB protein within the NF-kappaB signaling module.

Authors:  Soumen Basak; Hana Kim; Jeffrey D Kearns; Vinay Tergaonkar; Ellen O'Dea; Shannon L Werner; Chris A Benedict; Carl F Ware; Gourisankar Ghosh; Inder M Verma; Alexander Hoffmann
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

4.  IKKalpha shields 14-3-3sigma, a G(2)/M cell cycle checkpoint gene, from hypermethylation, preventing its silencing.

Authors:  Feng Zhu; Xiaojun Xia; Bigang Liu; Jianjun Shen; Yuhui Hu; Maria Person; Yinling Hu
Journal:  Mol Cell       Date:  2007-07-20       Impact factor: 17.970

5.  IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin.

Authors:  B Liu; J Willette-Brown; S Liu; X Chen; S M Fischer; Y Hu
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

6.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

7.  VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages.

Authors:  Pantelis Georgiades; Sarah Ogilvy; Hélène Duval; Diana R Licence; D Stephen Charnock-Jones; Stephen K Smith; Cristin G Print
Journal:  Genesis       Date:  2002-12       Impact factor: 2.487

8.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

Review 9.  Pax5: the guardian of B cell identity and function.

Authors:  César Cobaleda; Alexandra Schebesta; Alessio Delogu; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2007-05       Impact factor: 25.606

10.  NF-kB inhibitor blocks B cell development at two checkpoints.

Authors:  Biao Feng; Shuhua Cheng; Warren S Pear; Hsiou-Chi Liou
Journal:  Med Immunol       Date:  2004-03-29
View more
  17 in total

1.  NF-κB and AKT signaling prevent DNA damage in transformed pre-B cells by suppressing RAG1/2 expression and activity.

Authors:  Katarina Ochodnicka-Mackovicova; Mahnoush Bahjat; Timon A Bloedjes; Chiel Maas; Alexander M de Bruin; Richard J Bende; Carel J M van Noesel; Jeroen E J Guikema
Journal:  Blood       Date:  2015-07-07       Impact factor: 22.113

2.  Lymph node formation and B cell homeostasis require IKK-α in distinct endothelial cell-derived compartments.

Authors:  Kelly A McCorkell; Nipun Jayachandran; Michelle D Cully; Jacquelyn Freund-Brown; Tiffany Weinkopff; James Monslow; Yinling Hu; Ellen Puré; Bruce D Freedman; Jorge I Alvarez; Michael P Cancro; Michael J May
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-30       Impact factor: 11.205

3.  IKKα-Mediated Noncanonical NF-κB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.

Authors:  Brandon Cieniewicz; Varvara Kirillov; Isabel Daher; Xiaofan Li; Darby G Oldenburg; Qiwen Dong; Julie A Bettke; Kenneth B Marcu; Laurie T Krug
Journal:  J Virol       Date:  2022-04-28       Impact factor: 6.549

4.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

5.  The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

Authors:  Zuoxiang Xiao; Qun Jiang; Jami Willette-Brown; Sichuan Xi; Feng Zhu; Sandra Burkett; Timothy Back; Na-Young Song; Mahesh Datla; Zhonghe Sun; Romina Goldszmid; Fanching Lin; Travis Cohoon; Kristen Pike; Xiaolin Wu; David S Schrump; Kwok-Kin Wong; Howard A Young; Giorgio Trinchieri; Robert H Wiltrout; Yinling Hu
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

6.  Interactions between NF-κB and SP3 connect inflammatory signaling with reduced FGF-10 expression.

Authors:  Billy J Carver; Erin J Plosa; Amanda M Stinnett; Timothy S Blackwell; Lawrence S Prince
Journal:  J Biol Chem       Date:  2013-04-04       Impact factor: 5.157

7.  Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis.

Authors:  Vladimir R Babaev; Lei Ding; Youmin Zhang; James M May; P Charles Lin; Sergio Fazio; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-04       Impact factor: 8.311

8.  IKKα deficiency disrupts the development of marginal zone and follicular B cells.

Authors:  Mumtaz Y Balkhi; Jami Willette-Brown; Gabor Wittmann; Yinling Hu
Journal:  Genes Immun       Date:  2018-05-08       Impact factor: 2.676

9.  Disruption of the Myc-PDE4B regulatory circuitry impairs B-cell lymphoma survival.

Authors:  Jehyun Nam; Dong Uk Kim; Eungyoung Kim; Bomi Kwak; Min Ji Ko; Ah-Young Oh; Bum-Joon Park; Yea Woon Kim; AeRi Kim; Hokeun Sun; Youngmi Jung; Jae-Hoon Lee; Ho-Jin Shin; Inmyoung Park; Dae-Kyu Song; Jee-Yeong Jeong; Yun-Han Lee; Sang-Woo Kim
Journal:  Leukemia       Date:  2019-05-28       Impact factor: 11.528

10.  Constitutive activation of NF-κB during early bone marrow development results in loss of B cells at the pro-B-cell stage.

Authors:  Andrea Paun; Estefania Claudio; Ulrich K Siebenlist
Journal:  Blood Adv       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.